NL-OMON42370已完成不适用
HLA SUBTYPING IN ANTIBODY MEDIATED LIMBIC ENCEPHALITIS - HLA in limbic encephalitis
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 41
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Limbic encephalitis due to antibodies to LGI1, Caspr2, NMDAR, GABA-B or GAD65, recently or in the past
- •- Current age > 18 years
- •- Caucasoid race
排除标准
- •- Not mentally competent to give informed consent
- •- Patient is withholding informed consent, or objects after initial consent
研究者
相似试验
已完成
不适用
HLA Sensitization Following Major Cortical Allograft Bone ProceduresBone CancerNCT00160719University of Florida10
尚未招募
Unknown
se of soluble human leukocyte antigen as marker of embryo quality for clinical outcomes in women undergoing IVF/ICSI cyclesCTRI/2024/05/067437All India Institute of Medical Science
已完成
1 期
Predetermined Minor Histocompatibility Antigen-based Therapeutic or Prophylactic Peptide Vaccinations for Patients with Recurred Malignancies or Patients with High-Risk Malignancies Follwoing Allogeneic Hematopoietic Cell Transplantation.(1) Therapeutic vaccine: Any hematological malignancies recurred after allogineic hematopoietic transplanation as follows (RAEB, CMML, AML, ALL, CML, Multiple Myeloma, NHL). (2) Prophylactic vaccine: Hematological malignancies with high risk of relapse after allogineic hematopoietic transplanation as follows (RAEB, CMML, AML in >=3CR/non-CR or any AML with M0/M6/M7 FAB type, ALL in >=2CR/non-CR, CML in >=2CP or >=AP, Multiple Myeloma in PD, NHL in non-CR).JPRN-UMIN000000872Aichi Cancer Center Research Institute12
已完成
不适用
Phase II study of Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy for maintenance of Patients With Neovascular Maculopathyeovascular MaculopathyJPRN-UMIN000006372Department of Ophthalmology, Osaka University Medical School120
已完成
1 期
A phase I/II trial of HLA haploidentical peripheral blood stem cell transplantation following reduced-intensity conditioningChronic myeloid leukemia, Acute myeloid leukemia, Acute lymphoid leukemia, Myelodysplastic syndrome, Malignant lymphomaJPRN-C000000253Health and Labour Sciences Research Grants, Research on Human Genome, Tissue Engineering, Ministry of Health, Labour and Welfare25